Study outcomes at 6 months postinterventions
Outcomes | Adequate HL (total 145) | Inadequate HL (total 144) | RAMP-Individual Total | RAMP-Group Total | P value | ||||
RAMP-Individual (n=51) | RAMP-Group (n=94) | P value | RAMP-Individual (n=86) | RAMP-Group (n=58) | P value* | ||||
Any change of HT drugs
| 24 (47.1%) | 40 (42.6%) | 0.602 | 29 (33.7%) | 23 (39.7%) | 0.530 | 53 (38.7%) | 63 (41.4%) | 0.633 |
| 27 (52.9%) | 54 (57.4%) | 57 (66.3%) | 35 (60.3%) | 84 (61.3%) | 89 (58.6%) | |||
Change of body weight (kg, mean±SD) | 0.2±1.7 | −0.3±2.0 | 0.213 | 1.0±1.7 | −0.2±1.9 | <0.001 | 0.7±1.7 | −0.3±2.0 | <0.001 |
Fasting blood sugar (mmol/l, mean±SD) | 5.9±1.1 | 6.1±1.1 | 0.205 | 6.5±1.8 | 6.2±1.4 | 0.378 | 6.2±1.6 | 6.2±1.2 | 0.604 |
Low-density lipoprotein (mmol/l, mean±SD) | 3.1±1.0 | 2.9±0.8 | 0.330 | 2.8±0.9 | 3.1±0.9 | 0.107 | 2.9±0.9 | 3.0±0.8 | 0.608 |
HBPM practice | |||||||||
Own their BP devices (%) yes | 44 (86.3%) | 74 (78.7%) | 0.265 | 52 (60.4%) | 38 (65.5%) | 0.539 | 96 (70.1%) | 112 (73.7%) | 0.495 |
| 7 (13.7%) | 20 (21.3%) | 34 (39.5%) | 20 (34.5%) | 41 (29.9%) | 40 (26.3%) | |||
Measure BP at home in the past 6 months (%) Yes | 39 (76.5%) | 74 (78.7%) | 0.755 | 49 (57.0%) | 34 (58.6%) | 0.845 | 88 (64.2%) | 108 (71.1%) | 0.215 |
| 12 (23.5%) | 20 (21.3%) | 37 (43.0%) | 24 (41.3%) | 49 (35.8%) | 44 (28.9%) | |||
Frequency of HBPM
| 33 (64.7%) | 70 (74.5%) | 0.216 | 45 (52.3%) | 29 (50.0%) | 0.784 | 78 (56.9%) | 99 (65.1%) | 0.153 |
| 18 (35.3%) | 24 (25.5%) | 41 (47.7%) | 29 (50.0%) | 59 (43.1%) | 53 (34.9%) | |||
HBPM knowledge | |||||||||
HBPM Assessment Score (%) (N=272)†
| 12 (24.1%) | 63 (71.6%) | <0.001 | 15 (19.0%) | 35 (63.6%) | <0.001 | 27 (20.9%) | 98 (68.5%) | <0.001 |
| 38 (76.0%) | 25 (28.4%) | 64 (81.0%) | 20 (36.4%) | 102 (79.1%) | 45 (31.5%) |
*P value of proportions by Pearson χ2 tests; continuous variables by Student’s t-tests.
†17 participants refuse to answer knowledge score 6 month post-intervention
BP, blood pressure; HBPM, home blood pressure monitoring; HL, health literacy; HT, hypertension; RAMP, Risk Assessment and Management Programme.